Vascular endothelial growth factor (VEGF) has previously been demonstrated to accelerate compensatory lung growth (CLG) in mice and may be a useful therapy for pulmonary hypoplasia. This evidence concerns the gene VEGFA and Pulmonary hypoplasia.